In this study, the TUNEL assay and immunohistochemical staining showed that the apoptosis was decreased accompanied by increased Bcl-2 and decreased caspase-3 expression in the prevention group with EDHB administration, indicating that EDHB could interfere with apoptosis and prevent the occurrence of steroid-associated osteonecrosis. Here, BCL2 is linked to osteonecrosis.